Identification Generic Name (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE DrugBank Accession Number DB07107 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE (DB07107) ×  Close Weight Average: 370.447  Monoisotopic: 370.179361346  Chemical Formula C 23 H 22 N 4 O Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U cAMP-dependent protein kinase catalytic subunit alpha Not Available Humans U cAMP-dependent protein kinase inhibitor alpha Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Indoles and derivatives Sub Class Indoles Direct Parent 3-alkylindoles Alternative Parents Aralkylamines  /  Alkyl aryl ethers  /  Substituted pyrroles  /  Pyridines and derivatives  /  Benzenoids  /  Heteroaromatic compounds  /  Azacyclic compounds  /  Organopnictogen compounds  /  Monoalkylamines  /  Hydrocarbon derivatives Substituents 3-alkylindole  /  Alkyl aryl ether  /  Amine  /  Aralkylamine  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Benzenoid  /  Ether  /  Heteroaromatic compound  /  Hydrocarbon derivative Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key SGHXFHRRWFLILP-XJDXJNMNSA-N InChI InChI=1S/C23H22N4O/c24-20(12-19-14-27-23-4-2-1-3-22(19)23)16-28-21-11-18(13-26-15-21)6-5-17-7-9-25-10-8-17/h1-11,13-15,20,27H,12,16,24H2/b6-5+/t20-/m0/s1 IUPAC Name (2S)-1-(1H-indol-3-yl)-3-({5-[(1E)-2-(pyridin-4-yl)ethenyl]pyridin-3-yl}oxy)propan-2-amine SMILES [H][C@@](N)(COC1=CN=CC(\C=C\C2=CC=NC=C2)=C1)CC1=CNC2=C1C=CC=C2 References General References Not Available External Links PubChem Compound 6914613 PubChem Substance 99443578 ChemSpider 5290493 BindingDB 15022 ChEMBL CHEMBL383541 ZINC ZINC000014957382 PDBe Ligand 4EA PDB Entries 2f7x Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.000753 mg/mL ALOGPS logP 3.12 ALOGPS logP 3.09 Chemaxon logS -5.7 ALOGPS pKa (Strongest Acidic) 17.11 Chemaxon pKa (Strongest Basic) 9.24 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 76.82 Å 2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 111.74 m 3 ·mol -1 Chemaxon Polarizability 41.8 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.9876 Caco-2 permeable - 0.6341 P-glycoprotein substrate Substrate 0.5567 P-glycoprotein inhibitor I Non-inhibitor 0.9097 P-glycoprotein inhibitor II Non-inhibitor 0.5991 Renal organic cation transporter Inhibitor 0.5 CYP450 2C9 substrate Non-substrate 0.8584 CYP450 2D6 substrate Non-substrate 0.6492 CYP450 3A4 substrate Non-substrate 0.6141 CYP450 1A2 substrate Inhibitor 0.8983 CYP450 2C9 inhibitor Non-inhibitor 0.6688 CYP450 2D6 inhibitor Inhibitor 0.882 CYP450 2C19 inhibitor Non-inhibitor 0.5205 CYP450 3A4 inhibitor Inhibitor 0.5933 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.9013 Ames test Non AMES toxic 0.6412 Carcinogenicity Non-carcinogens 0.961 Biodegradation Not ready biodegradable 0.997 Rat acute toxicity 2.5676 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9059 hERG inhibition (predictor II) Non-inhibitor 0.6195    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  cAMP-dependent protein kinase catalytic subunit alpha Kind Protein Organism Humans Pharmacological action Unknown General Function Ubiquitin protein ligase binding Specific Function Phosphorylates a large number of substrates in the cytoplasm and the nucleus. Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which bin... Gene Name PRKACA Uniprot ID P17612 Uniprot Name cAMP-dependent protein kinase catalytic subunit alpha Molecular Weight 40589.38 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  
 
 
  Details 2.  cAMP-dependent protein kinase inhibitor alpha Kind Protein Organism Humans Pharmacological action Unknown General Function Protein kinase a catalytic subunit binding Specific Function Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulato... Gene Name PKIA Uniprot ID P61925 Uniprot Name cAMP-dependent protein kinase inhibitor alpha Molecular Weight 7988.435 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:18 / Updated at June 12, 2020 16:52 